You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets

Request The Product List ofOther Targets Other Targets

Cat. No. Product Name Information
PC-38162

PBENZ-DBRMD

DIO3 inhibitor

PBENZ-DBRMD is a first-in-class inhibitor of enzyme iodothyronine deiodinase type 3 (DIO3) with antitumor effects both in vitro and in vivo.
PC-38159

CADD522

RUNX2 inhibitor

CADD522 (CADD-522) is a small molecule that inhibits RUNX2-DNA binding and decreases RUNX2 transcriptional activity.
PC-38158

SCL-LMO2 inhibitor 3K7

SCL-LMO2 inhibitor

SCL-LMO2 inhibitor 3K7 is a small molecule, specific inhibitor of the SCL-LMO2 PPI, binds directly to LMO2 with Kd of 1.2 uM.
PC-38147

eCIRP/TREM-1 inhibitor M3

eCIRP/TREM-1 inhibitor M3 (RGFFRGG) is a small CIRP-derived peptide that inhibits the eCIRP/TREM-1 interaction.
PC-38144

InhiTinib

IFN-gamma inhibitor

InhiTinib is a small molecule that inhibit interferon (IFN)-gamma production (IC50=52.44 nM) and proliferation of primary CD3+ T cells without inducing cell death.
PC-38132

UAB126

UAB126 (UAB 126) is a novel rexinoid-like small molecule that show positive effects on metabolic syndrome without the known side effects of potent rexinoids.
PC-38128

DCZ0415

TRIP13 inhibitor

DCZ0415 (DCZ-0415) is a small-molecule inhibitor targeting TRIP13 with Kd of 2.42 uM in SPR assay.
PC-38123

SOX11 inhibitor Compound E

SOX11 inhibitor

SOX11 inhibitor Compound E (SOX11i) is a small molecule inhibitor of SOX11, bind directly to SOX11-DBD and interfere with DNA binding.
PC-38122

SOX11 inhibitor Compound R

SOX11 inhibitor Compound R (SOX11i) is a small molecule inhibitor of SOX11, bind directly to SOX11-DBD and interfere with DNA binding.
PC-38115

SLC6A19 inhibitor 39

SLC6A19 inhibitor

SLC6A19 inhibitor 39 is a potent, selective and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19) with IC50 of 35 nM.
PC-38114

T-690

T-690 is a potent, selective, oral inhibitor of glucosylceramide synthase (GCS) with IC50 of 15 nM.
PC-38105

RA 5557

UGT8 inhibitor

RA 5557 is a brain-penetrant, selective, oral UGT8 inhibitor, inhibits galactosylceramide biosynthesis.

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com